Toll-like receptor signaling pathway variants and prostate cancer mortality

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 6, 2009, Pages 1859-1863

  Stark, Jennifer Rider ^a,b   Wiklund, Fredrik ^c   Grönberg, Henrik ^c   Schumacher, Fredrick ^d   Sinnott, Jennifer A ^a   Stampfer, Meir J ^a,b   Mucci, Lorelei A ^a,b   Kraft, Peter ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

AGED; AGED, 80 AND OVER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 67449100030     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0981     Document Type: Article

References (22)

1. Amling CL. Prostate-specific antigen and detection of prostate cancer: what have we learned and what should we recommend for screening? Curr Treat Options Oncol 2006;7:337-345
2. Tryggvadottir L, Vidarsdottir L, Thorgeirsson T, et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 2007;99:929-935 (Pubitemid 47073499)
3. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in Europeans and African populations. Nat Genet 2006;38:652-658 (Pubitemid 43927306)
4. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-321 (Pubitemid 351311772)
5. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008;40:310-315 (Pubitemid 351311773)
6. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121:1571-1578 (Pubitemid 47328718)
7. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867
8. Platz EA, De Marzo AM. Epidemiology of inflammation and prostate cancer. J Urol 2004;271:S36-40. (Pubitemid 38090420)
9. Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol 2005;116:241-249 (Pubitemid 41096524)
10. Sun J, Wiklund F, Zheng SL, et al. Sequence variants in Toll-like receptor gene cluster (TLR6-1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005;97:525-532 (Pubitemid 40590434)
11. Shahedi K, Lindstrom S, Zheng SL, et al. Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer 2006;119:668-672 (Pubitemid 43955722)
12. Zheng SL, Augustsson-Balter K, Chang B, et al. Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden study. Cancer Res 2004;64:2918-2922 (Pubitemid 38500633)
13. Lindmark F, Zheng SL, Wiklund F, et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 2004;96:1248-1254 (Pubitemid 39232716)
14. Fall K, Strömberg F, Rosell J, Andrèn O, Varenhorst E. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008;42:352-7. In press.
15. Xu J, Lowey J, Wiklund F, et al. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2563-2568 (Pubitemid 41752716)
16. Kraft P, Cox DG, Paynter RA, Hunter DJ, De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005;28:261-272 (Pubitemid 40404580)
17. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002;53:79-91. (Pubitemid 34621657)
18. Stram DO, Leigh Pearce C, Bretsky P, et al. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003;55:179-190 (Pubitemid 37323455)
19. Cheng I, Krumroy LM, Plummer SJ, Casey G, Witte JS. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1309-1311 (Pubitemid 46984978)
20. Hayes VM, Severi G, Southey MC, et al. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol Biomarkers Prev 2006;15:1223-1225
21. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials 1990;11:116-128 (Pubitemid 20136185)
22. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 2003;4:587-597 (Pubitemid 36917501)